Zenas BioPharma, Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

31.27

-1.35 (-4.14%)

At close: Aug 28, 2026, 4:00 PM EDT

30.76

-0.51 (-1.63%)

After-hours: Aug 28, 2026, 7:43 PM EDT

Zenas BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	196.58	110.64	319.74	56.86	67.21
Short-Term Investments	446.55	232.55	31.02	-	-
Cash & Short-Term Investments	643.13	343.19	350.77	56.86	67.21
Cash Growth	135.34%	-2.16%	516.93%	-15.40%	-
Other Receivables	0.8	1.2	2	-	-
Receivables	0.8	1.2	2	-	-
Prepaid Expenses	9.87	6.78	3.07	1.65	1.24
Restricted Cash	-	-	0.09	-	-
Other Current Assets	-	-	-	1.3	-
Total Current Assets	653.79	351.17	355.92	59.8	68.44
Property, Plant & Equipment	0.84	1.39	1.19	1.01	1.8
Long-Term Investments	30.76	17.27	-	-	-
Long-Term Deferred Charges	0.49	0.71	-	1.39	-
Other Long-Term Assets	15.8	13.1	12.86	5.97	4.33
Total Assets	701.69	383.64	369.97	68.18	74.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	7.59	7.11	17.14	5.4	5.82
Accrued Expenses	57.41	54.31	39.16	17.01	19.44
Current Portion of Leases	0.82	1.12	0.79	0.56	0.72
Current Income Taxes Payable	-	0.12	0.21	0.3	-
Total Current Liabilities	65.82	62.65	57.29	23.26	25.97
Long-Term Debt	297.02	-	-	20.3	-
Long-Term Leases	0.02	0.21	0.22	0.26	0.81
Other Long-Term Liabilities	91.74	78.64	-	-	-
Total Liabilities	454.59	141.5	57.51	43.82	26.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	0	-	0
Additional Paid-In Capital	1,206	1,007	699.65	4.65	1.03
Retained Earnings	-957.57	-765.13	-387.39	-230.4	-193.28
Comprehensive Income & Other	-1.14	-0.06	0.19	0.04	-0.04
Total Common Equity	247.1	242.14	312.46	-225.72	-192.29
Shareholders' Equity	247.1	242.14	312.46	24.37	47.8
Total Liabilities & Equity	701.69	383.64	369.97	68.18	74.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	297.86	1.33	1	21.11	1.53
Net Cash (Debt)	345.27	341.87	349.76	35.74	65.68
Net Cash Growth	26.81%	-2.26%	878.52%	-45.58%	-
Net Cash Per Share	6.45	7.64	26.50	23.34	44.02
Filing Date Shares Outstanding	65.18	57.36	41.8	1.58	1.55
Total Common Shares Outstanding	63.33	54.49	41.79	1.58	1.55
Working Capital	587.98	288.52	298.63	36.55	42.48
Book Value Per Share	3.90	4.44	7.48	-143.15	-124.11
Tangible Book Value	247.1	242.14	312.46	-225.72	-192.29
Tangible Book Value Per Share	3.90	4.44	7.48	-143.15	-124.11

SEC Filings: 10-K · 10-Q